Neuroendocrine tumors treatment with I-131 Metaiodobenzylguanidine (MIBG)

Neuroendocrine tumors treatment with I-131 Metaiodobenzylguanidine (MIBG)

Background: I-131 Metaiodobenzylguanidine (MIBG) is a radiopharmaceutical which is proved effective in treatment of tumors with neuroendocrine origin, especially the neuroectodermal (sympathoadrenal) type, including pheochromocytoma, paraganglioma and neuroblastoma. It is also of some value in other...

Full description

Bibliographic Details
Main Authors: Armaghan Fard-fahani, Davood Beiki, Babak Fallahi, Alireza Emami-Ardakani, Mohsen Saghari, Mohammad Eftekhary
Format: Article
Language:English
Published: Bushehr University of Medical Sciences 2011-09-01
Series:Iranian South Medical Journal
Subjects:
pheochromocytoma
neuroblastoma
I-131 MIBG
carcinoid tumor
medullary thyroid carcinoma
neuroendocrine tumors
Online Access:http://ismj.bpums.ac.ir/browse.php?a_code=A-10-3-226&slc_lang=en&sid=1

Internet

http://ismj.bpums.ac.ir/browse.php?a_code=A-10-3-226&slc_lang=en&sid=1

Similar Items